Corient Capital Partners, LLC Johnson & Johnson Transaction History

Corient Capital Partners, LLC

$1.34 Billion
Q3 2022

A detailed history of Corient Capital Partners, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Corient Capital Partners, LLC holds 63,040 shares of JNJ stock, worth $9.11 Million. This represents 0.84% of its overall portfolio holdings.

Number of Shares

63,040

Previous 63,040 -0.0%

Holding current value

$9.11 Million

Previous $11.2 Million -0.0%

% of portfolio

0.84%

Previous 0.85%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$168.19 - $186.01 $1.12 Million - $1.24 Million	6,671 Added 11.83%	63,040 $11.2 Million
Q1 2022 May 16, 2022	BUY	$158.14 - $179.59 $631,927 - $717,641	3,996 Added 7.63%	56,369 $9.99 Million
Q4 2021 Feb 11, 2022	BUY	$155.93 - $173.01 $83,578 - $92,733	536 Added 1.03%	52,373 $8.96 Million
Q3 2021 Nov 16, 2021	BUY	$161.5 - $179.47 $92,055 - $102,297	570 Added 1.11%	51,837 $8.37 Million
Q2 2021 Aug 16, 2021	BUY	$159.48 - $171.07 $370,791 - $397,737	2,325 Added 4.75%	51,267 $8.45 Million
Q1 2021 May 17, 2021	BUY	$153.07 - $170.48 $132,711 - $147,806	867 Added 1.8%	48,942 $8.04 Million
Q4 2020 Feb 12, 2021	SELL	$137.11 - $157.38 $959,770 - $1.1 Million	-7,000 Reduced 12.71%	48,075 $7.57 Million
Q3 2020 Nov 16, 2020	BUY	$140.38 - $153.83 $115,251 - $126,294	821 Added 1.51%	55,075 $8.2 Million
Q2 2020 Aug 14, 2020	BUY	$128.81 - $155.51 $404,721 - $488,612	3,142 Added 6.15%	54,254 $7.63 Million
Q1 2020 May 06, 2020	BUY	$111.14 - $153.99 $66,795 - $92,547	601 Added 1.19%	51,112 $6.7 Million
Q4 2019 Feb 04, 2020	BUY	$127.5 - $146.44 $209,865 - $241,040	1,646 Added 3.37%	50,511 $7.37 Million
Q3 2019 Nov 06, 2019	BUY	$126.95 - $142.14 $96,228 - $107,742	758 Added 1.58%	48,865 $6.32 Million
Q2 2019 Aug 08, 2019	BUY	$131.15 - $144.24 $396,859 - $436,470	3,026 Added 6.71%	48,107 $6.7 Million
Q1 2019 May 10, 2019	BUY	$125.72 - $139.79 $1.35 Million - $1.5 Million	10,738 Added 31.27%	45,081 $6.3 Million
Q4 2018 Feb 07, 2019	BUY	$122.84 - $147.84 $1.28 Million - $1.54 Million	10,416 Added 43.53%	34,343 $4.43 Million
Q2 2018 Oct 02, 2018	BUY	$119.4 - $131.76 $1.17 Million - $1.29 Million	9,803 Added 69.41%	23,927 $2.9 Million
Q1 2018 May 14, 2018	BUY	$125.1 - $148.14 $109,087 - $129,178	872 Added 6.58%	14,124 $1.81 Million
Q4 2017 Feb 13, 2018	BUY	$131.22 - $143.62 $2,361 - $2,585	18 Added 0.14%	13,252 $1.85 Million
Q3 2017 Nov 14, 2017	SELL	$129.47 - $135.38 $17.1 Million - $17.9 Million	-132,387 Reduced 90.91%	13,234 $0
Q2 2017 Aug 14, 2017	BUY	N/A	287 Added 0.2%	145,621 $19.3 Million
Q1 2017 Aug 17, 2017	BUY	N/A	142,117 Added 4417.69%	145,334 $18.1 Million
Q1 2017 Aug 14, 2017	BUY	N/A	3,217	3,217 $314,000

Others Institutions Holding JNJ

# of Institutions

4,275

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $378B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Corient Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Corient Capital Partners, LLC with notifications on news.

Account

Corient Capital Partners, LLC Johnson & Johnson Transaction History